Literature DB >> 8081481

Determination of fosfomycin in biological fluids by capillary electrophoresis.

D Levêque1, C Gallion, E Tarral, H Monteil, F Jehl.   

Abstract

A capillary electrophoresis method was developed for the determination of the antibiotic fosfomycin in serum, cerebrospinal fluid and aqueous humor. The technique uses indirect UV detection and the working buffer includes an organic cation to improve fosfomycin mobility. The electrophoretic time of migration is less than 7 min in both fluids. The limit of quantification is 2.5 and 1 microgram/ml in serum and aqueous fluids, respectively (signal-to-noise ratio = 3). The method was validated in serum and water over the concentration range 2.5-200 micrograms/ml. The calibration graph for serum was linear with a correlation coefficient r = 0.999. At a fosfomycin concentration of 2.5 micrograms/ml in serum, the intra- and inter-day precisions (coefficients of variation) were 5 and 5.2%, respectively. The mean recovery in serum was 94.5% (S.D. = 2.4%).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8081481     DOI: 10.1016/0378-4347(94)00095-6

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  3 in total

Review 1.  Capillary electrophoresis in pharmaceutical analysis.

Authors:  L A Holland; N P Chetwyn; M D Perkins; S M Lunte
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

2.  Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa.

Authors:  Y Q Xiong; G Potel; J Caillon; G Stephant; F Jehl; D Bugnon; P Le Conte; D Baron; H Drugeon
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

3.  Bactericidal effect of pefloxacin and fosfomycin against Pseudomonas aeruginosa in a rabbit endocarditis model with pharmacokinetics of pefloxacin in humans simulated in vivo.

Authors:  D Bugnon; G Potel; Y Q Xiong; J Caillon; D Navas; C Gras; M F Kergueris; P Le Conte; F Jehl; D Baron; H Drugeon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-08       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.